2024
Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia
ÇELIKER, Canan; Štefan ZELENÁK; Samuel LIETAVA; Jiří PACHERNÍK; Markéta BÉBAROVÁ et. al.Basic information
Original name
Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia
Authors
ÇELIKER, Canan; Štefan ZELENÁK; Samuel LIETAVA; Jiří PACHERNÍK; Markéta BÉBAROVÁ ORCID; Jana ZÍDKOVÁ ORCID; Tomáš NOVOTNÝ and Tomáš BÁRTA
Edition
Stem cell research, Amsterdam, Elsevier, 2024, 1873-5061
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
10601 Cell biology
Country of publisher
Netherlands
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 0.700
RIV identification code
RIV/00216224:14110/24:00137190
Organization unit
Faculty of Medicine
UT WoS
001302477700001
EID Scopus
2-s2.0-85201767014
Keywords in English
human induced pluripotent stem cell lines; RYR2
Tags
International impact, Reviewed
Changed: 26/3/2025 13:04, Mgr. Tereza Miškechová
Abstract
In the original language
Human induced pluripotent stem cell (iPSC) lines were generated from peripheral blood mononuclear cells (PBMCs) isolated from two related patients diagnosed with either idiopathic ventricular fibrillation or catecholaminergic polymorphic ventricular tachycardia, carrying an unknown variant in the RYR2 gene, c.14201A>G (p.Y4734C) and one healthy related individual. Reprogramming was done using a commercially available Epi5 Reprogramming Kit. The pluripotency of the iPSC lines was verified by the expression of pluripotency markers and by their capacity to differentiate into all three embryonic germ layers in vitro. These iPSC lines are available for functional analysis and in vitro studies of RYR2 channelopathy.
Links
| MUNI/A/1598/2023, interní kód MU |
| ||
| NU22-02-00348, research and development project |
|